You are here

  • Home
  • Archive
  • Volume 12, Issue 3
  • rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors

Citation Tools

Article menu
Basic tumor immunology
Original research
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lee M, Im S, Baek S, et al
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2024;12:e008001. doi: 10.1136/jitc-2023-008001